
|Articles|March 1, 2001
The American Journal of Managed Care
- March 2001
- Volume 7
- Issue 3
Renal Effects of Angiotensin-Converting Enzyme Inhibitors That Result in Cost Savings and Improved Patient Outcomes
Advertisement
Articles in this issue
almost 25 years ago
Prior-Authorization Requirements for Patient Referrals to Specialistsalmost 25 years ago
Assessing Safety of New Technology: Conference Looks at Evaluation Processalmost 25 years ago
Physician Perceptions of a National Formularyalmost 25 years ago
Are Patients' Chief Complaints Generally Specific to One Organ System?Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
5 Key Health Care Changes During Trump’s First Year Back in Office
2
J&J Agreement Brings 15 of 17 Pharma Companies Into Trump's Drug-Pricing Effort
3
Maternal Morbidity Increased in States Enacting TRAP Laws
4
Zanidatamab Shows Breakthrough Survival Gains in Metastatic Gastroesophageal Cancer: Elena Elimova, MD
5



























































